Florian Fuchs
Overview
Explore the profile of Florian Fuchs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Fuchs F, Koenig A, Poppitz D, Hahnel S
J Dent
. 2020 Oct;
102:103495.
PMID: 33038439
Objectives: The goal of this study was to show the potential of the inexpensive macro photography technique for application in various fields of contemporary dental materials science. The method was...
32.
Fu Y, Estoppey D, Roggo S, Pistorius D, Fuchs F, Studer C, et al.
Nat Commun
. 2020 Aug;
11(1):3913.
PMID: 32737318
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
33.
Fu Y, Estoppey D, Roggo S, Pistorius D, Fuchs F, Studer C, et al.
Nat Commun
. 2020 Jul;
11(1):3387.
PMID: 32636417
Biosynthesis of glycosylphosphatidylinositol (GPI) is required for anchoring proteins to the plasma membrane, and is essential for the integrity of the fungal cell wall. Here, we use a reporter gene-based...
34.
Schulz-Kuhnt A, Greif V, Hildner K, Knipfer L, Dobronti M, Zirlik S, et al.
Front Immunol
. 2020 May;
11:691.
PMID: 32457736
Cystic fibrosis patients suffer from a progressive, often fatal lung disease, which is based on a complex interplay between chronic infections, locally accumulating immune cells and pulmonary tissue remodeling. Although...
35.
Marx U, Akabane T, Andersson T, Baker E, Beilmann M, Beken S, et al.
ALTEX
. 2020 Mar;
37(3):365-394.
PMID: 32113184
The first microfluidic microphysiological systems (MPS) entered the academic scene more than 15 years ago and were considered an enabling technology to human (patho)biology in vitro and, therefore, provide alternative...
36.
Miersch S, Konig A, Mehlhorn S, Fuchs F, Hahnel S, Rauch A
Clin Oral Investig
. 2019 Dec;
24(9):3009-3016.
PMID: 31807923
Objectives: The aim of this study was to analyse the impact of different clinical conditioning approaches and an ammonium polyfluoride- and trimethoxysilylpropyl methacrylate-based experimental primer for intraoral luting of buccal...
37.
Fuchs F, Schneider F, Kolinsky P, Serafin S, Bokelmann G
Sci Rep
. 2019 Sep;
9(1):13027.
PMID: 31506593
On September 1st, 2018 a devastating explosion occurred on the facility of an oil refinery near Ingolstadt, Germany. We analyzed data of 400 permanent and temporary seismic stations and find...
38.
Fuchs F, Gemming S, Schuster J
J Phys Condens Matter
. 2019 May;
31(35):355002.
PMID: 31108482
A model is presented which describes reconfigurable field-effect transistors (RFETs) with metal contacts, whose switching is controlled by manipulating the Schottky barriers at the contacts. The proposed modeling approach is...
39.
Hetenyi G, Molinari I, Clinton J, Bokelmann G, Bondar I, Crawford W, et al.
Surv Geophys
. 2019 Apr;
39(5):1009-1033.
PMID: 30956376
The AlpArray programme is a multinational, European consortium to advance our understanding of orogenesis and its relationship to mantle dynamics, plate reorganizations, surface processes and seismic hazard in the Alps-Apennines-Carpathians-Dinarides...
40.
Erber R, Stohr R, Herlein S, Giedl C, Rieker R, Fuchs F, et al.
Anticancer Res
. 2017 Dec;
37(12):6771-6778.
PMID: 29187455
Background: Immunohistochemical (IHC) assessment of programmed death-ligand 1 (PD-L1) in non-small cell lung cancer (NSCLC) has become important since the development of anti-PD-1/-PD-L1 directed drugs. Various PD-L1 antibodies and cut-offs...